Artykuły w czasopismach na temat „B. E. Robuck, Inc”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „B. E. Robuck, Inc”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Bartolome, Amelita, Anna Almazan, Salina Abusali, Stanley Tam, Eric Lee, Amogh Changavi, Wendy Trinh i in. "1089. Analytical Performance of an Ultrasensitive Immunoassay for Detection of Clostridium difficile Toxins in Stool". Open Forum Infectious Diseases 5, suppl_1 (listopad 2018): S326. http://dx.doi.org/10.1093/ofid/ofy210.924.
Pełny tekst źródłaGomperts, Edward D., Shashikant Apte, Utpal Chaudhuri, Joseph M. John, Vijay Ramanan, Ri Liesner, Amy D. Shapiro, Bonnie J. Mills i Martin Lee. "IB1001, an Investigational Recombinant Factor IX, Pharmacokinetics in Pediatric Patients with Hemophilia B." Blood 120, nr 21 (16.11.2012): 2225. http://dx.doi.org/10.1182/blood.v120.21.2225.2225.
Pełny tekst źródłaKarasiewicz, Kathy, Shuyang He, Mary Ng, Kristina Tess, Weifang Ling, Gunnar F. Kaufmann, Jerome B. Zeldis, Henry Ji, Robert Hariri i Xiaokui Zhang. "Preclinical Evaluation of Human Placental-Derived Allogeneic CD19 CAR-T Cells Against B Cell Malignancies". Blood 134, Supplement_1 (13.11.2019): 3222. http://dx.doi.org/10.1182/blood-2019-130782.
Pełny tekst źródłaCoyne-Beasley, Tamera, Joseph Bocchini, Alejandro Cane, Cindy Burman, Maria J. Tort i Jessica Presa. "01. Serum Bactericidal Activity Against Circulating and Reference Strains of Meningococcal Serogroup B in the United States: A Review of Meningococcal Serogroup B (MenB) Vaccines in Adolescents and Young Adults". Open Forum Infectious Diseases 8, Supplement_1 (1.11.2021): S124—S125. http://dx.doi.org/10.1093/ofid/ofab466.204.
Pełny tekst źródłaLasater, Elisabeth A., An D. Do, Luciana Burton, Yijin Li, Erin Williams, Jason Oeh, Luciana Molinero i in. "Resistance of Natural Killer and T Cells to Venetoclax Allows for Combination Treatment with Cancer Immunotherapy Agents". Blood 132, Supplement 1 (29.11.2018): 1118. http://dx.doi.org/10.1182/blood-2018-99-116405.
Pełny tekst źródłaHe, Jie, Jose A. Bufill, Michelle K. Nahas, Kai Wang, Lauren E. Young, Kristina M. Knapp, Kristina W. Brennan i in. "Clinical Utility of Comprehensive Profiling of Genomic Alterations in Hematologic Malignancies". Blood 124, nr 21 (6.12.2014): 1072. http://dx.doi.org/10.1182/blood.v124.21.1072.1072.
Pełny tekst źródłaGe, Jianning, Chunhui Yang, Jing Sun, Jiao Chen, Shuyi Qiu, Wenjie Yin, Lianjun Shen, Martina Sersch, Wei Cao i Xinxin Wang. "Preclinical Results of an Allogeneic, Universal CD19/CD7-Targeting CAR-T Cell Therapy (GC502) for B Cell Malignancies". Blood 138, Supplement 1 (5.11.2021): 1722. http://dx.doi.org/10.1182/blood-2021-148500.
Pełny tekst źródłaLilley, Graham, Alden Ladd, Daniel Cossette, Laura Viggiano, Gregory Hopkins, John W. Evans, Mingli Li i in. "Characterization of Lentiviral Vector Derived Anti-Bcma CAR T Cells Reveals Key Parameters for Robust Manufacturing of Cell-Based Gene Therapies for Multiple Myeloma". Blood 126, nr 23 (3.12.2015): 3243. http://dx.doi.org/10.1182/blood.v126.23.3243.3243.
Pełny tekst źródłaTran, Thai Hong, Krupa Scott, Shyun-Shyun Lee, Reshma Singh, Shawn Cogan, Jennifer Bordeaux, Hummel Jennifer i in. "Quantitative Multiplexed Immunohistochemistry Assays for Exploring CAR Modified T Cells and Checkpoint Inhibitors in Lymphoma Trials". Blood 126, nr 23 (3.12.2015): 2659. http://dx.doi.org/10.1182/blood.v126.23.2659.2659.
Pełny tekst źródłaTotman, Jennifer, Dorothy Brach, Vinny Motwani, Selene Howe, Emily Deutschman, John Lampe, Thomas V. Riera i in. "Pharmacologic Inhibition of the Histone Methyltransferase SETD2 with EZM0414 As a Novel Therapeutic Strategy in Relapsed or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma". Blood 138, Supplement 1 (5.11.2021): 1142. http://dx.doi.org/10.1182/blood-2021-151147.
Pełny tekst źródłaSchomer, Nathan Thomas, Laurent Boissel, Karen Jiang, Hans Klingemann, John H. Lee i Patrick Soon-Shiong. "Providing a Homing Receptor for CAR Engineered NK Cells - Improving Cellular Immunotherapy for B-Cell Lymphoma". Blood 132, Supplement 1 (29.11.2018): 4547. http://dx.doi.org/10.1182/blood-2018-99-116890.
Pełny tekst źródłaChang, Kai-Hsin, Minerva Sanchez, Jack Heath, Edouard deDreuzy, Scott Haskett, Abigail Vogelaar, Kiran Gogi i in. "Comparative Studies Reveal Robust HbF Induction By Editing of HBG1/2 Promoters or BCL11A Erythroid-Enhancer in Human CD34+ Cells but That BCL11A Erythroid-Enhancer Editing Is Associated with Selective Reduction in Erythroid Lineage Reconstitution in a Xenotransplantation Model". Blood 132, Supplement 1 (29.11.2018): 409. http://dx.doi.org/10.1182/blood-2018-99-114780.
Pełny tekst źródłaCampbell, Veronica, Ryan Thompson, Vivian Villegas, Jennifer Proctor, Karen McGovern, Jeffery L. Kutok i Howard M. Stern. "The Potent PI3K-δ,γ Inhibitor IPI-145 Exhibits Differential Activity In Diffuse Large B-Cell Lymphoma (DLBCL) Cell Lines". Blood 122, nr 21 (15.11.2013): 1832. http://dx.doi.org/10.1182/blood.v122.21.1832.1832.
Pełny tekst źródłaToudjarska, Ivanka, Zuhua Cai, Tim Racie, Julia Hettinger, Stuart Milstein, Brian R. Bettencourt, Dinah WY Sah, David Bumcrot, John Maraganore i Akshay Vaishnaw. "RNAi-Mediated Inhibition of Activated Protein C- A New Approach for Hemophilia Treatment". Blood 118, nr 21 (18.11.2011): 1204. http://dx.doi.org/10.1182/blood.v118.21.1204.1204.
Pełny tekst źródłaStorhoff, James, Brett Wallden, Rita M. Braziel, Catherine Thieblemont, Tressa Hood, Harini Ravi, Shannon Dennis i in. "Analytical Performance of Nanostring's Companion Diagnostic (CDx) Lymphoma Subtyping Test (LST) with Diffuse Large B-Cell Lymphoma Core Needle Biopsy Samples". Blood 126, nr 23 (3.12.2015): 1481. http://dx.doi.org/10.1182/blood.v126.23.1481.1481.
Pełny tekst źródłaCoiffier, Bertrand, Juan-Manuel Sancho, Wojciech Jurczak, Jin Seok Kim, Raj V. Nagarkar, Edvard Zhavrid, Jose Angel Hernandez Rivas i in. "Pharmacokinetic and Safety of CT-P10, a Biosimilar Candidate to the Rituximab Reference Product, in Patients with Newly Diagnosed Advanced Stage Follicular Lymphoma (AFL)". Blood 128, nr 22 (2.12.2016): 1807. http://dx.doi.org/10.1182/blood.v128.22.1807.1807.
Pełny tekst źródłaGanesan, Harish, Vipul Kumar, Sujata M. Bhavnani, David Melnick i Christopher M. Rubino. "1105. Population Pharmacokinetic Analyses for Tebipenem After the Administration of Tebipenem Pivoxil Hydrobromide". Open Forum Infectious Diseases 8, Supplement_1 (1.11.2021): S644—S645. http://dx.doi.org/10.1093/ofid/ofab466.1299.
Pełny tekst źródłaMerrill, J. T., J. Guthridge, D. Zack, P. Foster, B. Burington, L. Tran, M. Smith i J. A. James. "SAT0187 DISCRIMINATION OF SYSTEMIC LUPUS (SLE) PATIENTS WITH CLINICAL RESPONSE TO OBEXELIMAB (XMAB®5871) BASED ON A PATTERN OF IMMUNOLOGIC MARKERS". Annals of the Rheumatic Diseases 79, Suppl 1 (czerwiec 2020): 1035–36. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2972.
Pełny tekst źródłaDias, Lizalynn, Venkata Thodima, Geetu Mendiratta, Guttapalli Asha, Camille Gonzalez, Jocelyn C. Maragulia, Andrew D. Zelenetz, Julie Teruya Feldstein, Raju S. K. Chaganti i Jane Houldsworth. "Cross-Platform Assessment Of Genomic Imbalance In Diffuse Large B-Cell Lymphoma Identifies Novel Candidate Loci and Genes With Prognostic Value and Roles In Lymphomagenesis". Blood 122, nr 21 (15.11.2013): 4259. http://dx.doi.org/10.1182/blood.v122.21.4259.4259.
Pełny tekst źródłaHsieh, Y. T., C. Hubeau, V. Massa, W. LI, S. Frei, B. Capraro, A. Umana i in. "OP0316 EMERGING BEST-IN-CLASS IL-2 VARIANT HIGHLIGHTS TREG-DIRECTED THERAPY FOR AUTOIMMUNE DISEASE". Annals of the Rheumatic Diseases 79, Suppl 1 (czerwiec 2020): 195.1–195. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1999.
Pełny tekst źródłaHarrington, Deirdre M., Sarahjane Belton, Tara Coppinger, Muireann Cullen, Alan Donnelly, Kieran Dowd, Teresa Keating i in. "Results from Ireland’s 2014 Report Card on Physical Activity in Children and Youth". Journal of Physical Activity and Health 11, s1 (styczeń 2014): S63—S68. http://dx.doi.org/10.1123/jpah.2014-0166.
Pełny tekst źródłaRiley, Brigit E., Jeff Boonsripisal, Alicia Goodwin, Dominique Cartier, Eudean Garces, Kate Nesbitt, Courtney Dwyer i in. "Development of an Optimized rAAV2/6 Human Factor 8 cDNA Vector Cassette for Hemophilia a Gene Therapy". Blood 128, nr 22 (2.12.2016): 1173. http://dx.doi.org/10.1182/blood.v128.22.1173.1173.
Pełny tekst źródłaDias, Lizalynn, Venkata Thodima, Asha Guttapalli, Geetu Mendiratta, Sergei I. Syrbu i Jane Houldsworth. "Robust Assessment of Genomic Imbalance in Diffuse Large B-Cell Lymphoma Confirms Inferior Outcome Is Associated with Genomic Complexity and Identifies Potential Therapeutic Pathway Targets". Blood 124, nr 21 (6.12.2014): 2993. http://dx.doi.org/10.1182/blood.v124.21.2993.2993.
Pełny tekst źródłaAnguela, Xavier M., Rajiv Sharma, Yannick Doyon, Sunnie Y. Wong, David E. Paschon, Hojun Li, Virginia Haurigot i in. "In Vivo Genome Editing of Liver Albumin for Therapeutic Gene Expression: Rescue of Hemophilic Mice Via Integration of Factor 9". Blood 120, nr 21 (16.11.2012): 751. http://dx.doi.org/10.1182/blood.v120.21.751.751.
Pełny tekst źródłaTimmerman, John M., Kristopher K. Steward, Reiko E. Yamada, Patricia A. Young, Dena M. Minning, Raj K. Sachdev, Michael J. Gresser, Sanjay D. Khare i Sherie L. Morrison. "Antibody-Interferon-Alpha Fusion Protein Therapy for the Treatment of B-Cell Non-Hodgkin Lymphoma: Enhanced ADCC, Inhibition of Proliferation, and In Vivo Eradication of CD20+ Human Lymphomas". Blood 126, nr 23 (3.12.2015): 2762. http://dx.doi.org/10.1182/blood.v126.23.2762.2762.
Pełny tekst źródłaChekmasova, Alena A., Holly M. Horton, Tracy E. Garrett, John W. Evans, Johanna Griecci, Amanda Hamel, Howard J. Latimer i in. "A Novel and Highly Potent CAR T Cell Drug Product for Treatment of BCMA-Expressing Hematological Malignances". Blood 126, nr 23 (3.12.2015): 3094. http://dx.doi.org/10.1182/blood.v126.23.3094.3094.
Pełny tekst źródłaYounes, Anas, Connie Lee Batlevi, Jonathon B. Cohen, Sven de Vos, Daniel J. Landsburg, Zaw Win Myint, Krish Patel i in. "A Multi-Center Dose-Finding Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Fimepinostat (CUDC-907) in Combination with Venetoclax in Patients with Relapsed/Refractory (R/R) Lymphoma". Blood 134, Supplement_1 (13.11.2019): 4104. http://dx.doi.org/10.1182/blood-2019-128857.
Pełny tekst źródłaBjordahl, Ryan, Raedun Clarke, Svetlana Gaidarova, Brian Groff, Paul Rogers, Stacey Moreno, Ramzey Abujarour i in. "Off-the-Shelf Natural Killer Cell Immunotherapy for Enhanced Antibody Directed Cellular Cytotoxicity". Blood 128, nr 22 (2.12.2016): 3363. http://dx.doi.org/10.1182/blood.v128.22.3363.3363.
Pełny tekst źródłaSommer, Cesar, Hsin-Yuan Cheng, Yik Andy Yeung, Duy Nguyen, Janette Sutton, Zea Melton, Julien Valton i in. "Preclinical Evaluation of ALLO-819, an Allogeneic CAR T Cell Therapy Targeting FLT3 for the Treatment of Acute Myeloid Leukemia". Blood 134, Supplement_1 (13.11.2019): 3921. http://dx.doi.org/10.1182/blood-2019-129025.
Pełny tekst źródłaRichon, Victoria M., Christopher J. Sneeringer, Margaret Porter Scott, Kevin W. Kuntz, Sarah K. Knutson, Roy M. Pollock i Robert A. Copeland. "Lymphoma-Associated Mutations of EZH2 Result In a Change-of-Function". Blood 116, nr 21 (19.11.2010): 707. http://dx.doi.org/10.1182/blood.v116.21.707.707.
Pełny tekst źródłaHuard, Justin, Laurie Tatalick, Carl Walkey i Ryan Swanson. "NL-201, a De Novo Agonist of IL-2 and IL-15 Receptors, Demonstrates Synergistic Antitumor Activity with Anti-PD-1 Checkpoint Inhibitor Therapy in a Preclinical Non-Hodgkin Lymphoma Model". Blood 138, Supplement 1 (5.11.2021): 4560. http://dx.doi.org/10.1182/blood-2021-148885.
Pełny tekst źródłaGyurkocza, Boglarka, Rajneesh Nath, Patrick J. Stiff, Edward Agura, Mark Litzow, Ben Tomlinson, Hannah K. Choe i in. "Re-Induction and Targeted Conditioning with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Leads to High Rates of Transplantation and Successful Engraftment in Older Patients with Active, Relapsed or Refractory (rel/ref) AML after Failure of Chemotherapy and Targeted Agents: Preliminary Midpoint Results from the Prospective, Randomized Phase 3 Sierra Trial". Blood 134, Supplement_1 (13.11.2019): 5642. http://dx.doi.org/10.1182/blood-2019-122776.
Pełny tekst źródłaStorms, Robert W., Congxiao Liu, Elisabeth T. Tracy, Tracy Gentry, Andrew Balber i Joanne Kurtzberg. "ALDHbr Hematopoietic Progenitors Promote Short-Term Engraftment in Experimental Models for Cord Blood Transplantation." Blood 114, nr 22 (20.11.2009): 2433. http://dx.doi.org/10.1182/blood.v114.22.2433.2433.
Pełny tekst źródłaRosen, David B., James A. Cordeiro, David M. Soper, Ying-Wen Huang, Donna E. Hogge, Roland B. Walter, Alessandra Cesano i Wendy J. Fantl. "Distinct Signaling Profiles of Gemtuzumab Ozogamicin Responsiveness and Refractoriness in Acute Myeloid Leukemia." Blood 114, nr 22 (20.11.2009): 2745. http://dx.doi.org/10.1182/blood.v114.22.2745.2745.
Pełny tekst źródłaHowell, Stephen B., Hongying Zhang i William G. Rice. "A Phase 1a/b Dose Escalation Study of Apto-253 in Patients with Relapsed or Refractory AML or High-Risk MDS". Blood 134, Supplement_1 (13.11.2019): 5148. http://dx.doi.org/10.1182/blood-2019-129685.
Pełny tekst źródłaSteen, Chloe B., Bogdan A. Luca, Mohammad Shahrokh Esfahani, Barzin Y. Nabet, Brian Sworder, Farshad Farshidfar, Kiarash Shamardani i in. "An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma". Blood 134, Supplement_1 (13.11.2019): 655. http://dx.doi.org/10.1182/blood-2019-129461.
Pełny tekst źródłaStapleton, Ann, Aurelio Silvestroni, Pacita Roberts, Marsha Cox, Hillary Hayden, Mitchell Brittnacher, Samuel Miller i Thomas Hooton. "126. Robust and Persistent Vaginal Colonization with LACTIN-V Vaginal Lactobacillus crispatus Probiotic in a Double-Blind, Placebo-Controlled (DBPC) Phase 2b Trial to Prevent Recurrent UTI (rUTI)". Open Forum Infectious Diseases 5, suppl_1 (listopad 2018): S8. http://dx.doi.org/10.1093/ofid/ofy209.016.
Pełny tekst źródłaSmolen, J. S., F. Behrens, S. Liu Leage, C. Sapin, I. De La Torre, G. Meszaros, G. Schett i in. "AB0841 TARGET OUTCOMES IN PsA: SIMULTANEOUS ACHIEVEMENT of ACR50-PASI100 AND BEYOND: INSIGHTS FROM SPIRIT-H2H AT WEEK 24". Annals of the Rheumatic Diseases 79, Suppl 1 (czerwiec 2020): 1726.2–1727. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2884.
Pełny tekst źródłaFang, Riguo, Yingchi Zhang, Pengfei Yuan, Huihui Yang, Lingling Yu, Yongjian Zhang, Jia Shi i in. "Highly Efficient Gene Editing of Human Hematopoietic Stem Cells to Treat X-Linked Sideroblastic Anemia". Blood 136, Supplement 1 (5.11.2020): 1. http://dx.doi.org/10.1182/blood-2020-140208.
Pełny tekst źródłaLawrence, Jody, Nicholas Kitchin, Annaliesa S. Anderson, Michael W. Pride, Kathrin U. Jansen, William C. Gruber, Yahong Peng, Kevin Yi, Charles Knirsch i Chris Webber. "12. Randomized Studies of Two Clostridioides (Clostridium) difficile Vaccine Formulations". Open Forum Infectious Diseases 7, Supplement_1 (1.10.2020): S29. http://dx.doi.org/10.1093/ofid/ofaa439.057.
Pełny tekst źródłaLoveday, Kenneth, Doriana Froim, Anna Pisania, Alissa Fernald, Mathew Spaits, R. Scott Pearsall, Ravi Kumar i Kathryn W. Underwood. "ACE-536, a Novel GDF-Trap, Increases Hemoglobin, Hematocrit, and Red Blood Cell Levels in Rats and Monkeys." Blood 114, nr 22 (20.11.2009): 3603. http://dx.doi.org/10.1182/blood.v114.22.3603.3603.
Pełny tekst źródłaSrinivasan, Surabhi, Nguyen Tan, Hsin-Yuan Cheng, Yi Zhang, Silvia Tacheva-Grigorova, Tom Van Blarcom, Cesar Sommer, Duy Nguyen, Barbra Sasu i Siler Panowski. "Investigation of ALLO-316: A Fratricide-Resistant Allogeneic CAR T Targeting CD70 As a Potential Therapy for the Treatment of AML". Blood 136, Supplement 1 (5.11.2020): 23. http://dx.doi.org/10.1182/blood-2020-142161.
Pełny tekst źródłaPeterson, James, Daniel Drazan, Hanna Czajka, Jason Maguire, Jean-Louis Pregaldien, Ilkka Seppa, Roger Maansson i in. "6. Pentavalent Meningococcal (MenABCWY) Vaccine is Safe and Well Tolerated With Immunogenicity Noninferior to Coadministered MenB-FHbp and MenACWY-CRM in a Phase 2 Study of Healthy Adolescents and Young Adults". Open Forum Infectious Diseases 7, Supplement_1 (1.10.2020): S25—S26. http://dx.doi.org/10.1093/ofid/ofaa439.051.
Pełny tekst źródłaSmith, Pascal, Evelyn Teh, Ken Chisholm, Susanne Penny, Devanand Pinto, Kelcey Patterson, Brennan Dirk i in. "Proteomic analysis of plasma exosomes as biomarkers of response to MVP-S based immunotherapy". Journal of Immunology 208, nr 1_Supplement (1.05.2022): 66.09. http://dx.doi.org/10.4049/jimmunol.208.supp.66.09.
Pełny tekst źródłaCichocki, Frank, Ryan Bjordahl, Svetlana Gaidarova, Sajid Mahmood, Paul Rogers, Moyar Q. Ge, Dan S. Kaufman, Sarah Cooley, Bahram Valamehr i Jeffrey S. Miller. "iPSC-Derived NK Cells and Anti-PD-1 Antibody Synergize to Enhance T Cell Cytokine and Cytolytic Responses Against Multiple Tumors". Blood 132, Supplement 1 (29.11.2018): 730. http://dx.doi.org/10.1182/blood-2018-99-114893.
Pełny tekst źródłaZinzani, Pier Luigi, Vladimir Melnichenko, Krimo Bouabdallah, Jan Walewski, Alejandro Majlis, Laura Fogliatto, Dolores Caballero i in. "Pembrolizumab Monotherapy in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): 3-Year Follow-up of the Keynote-170 Study". Blood 136, Supplement 1 (5.11.2020): 42–43. http://dx.doi.org/10.1182/blood-2020-137080.
Pełny tekst źródłaNowakowski, Grzegorz, Annalisa Chiappella, Fangxin Hong, Randy D. Gascoyne, David W. Scott, William R. Macon, Rebecca L. King i in. "Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 Studies". Blood 134, Supplement_1 (13.11.2019): 4092. http://dx.doi.org/10.1182/blood-2019-123083.
Pełny tekst źródłaMartinowitz, Uri, Amy D. Shapiro, Doris V. Quon, Miguel Antonio Escobar, Christine L. Kempton, Peter Collins, Pratima Chowdary i in. "Pharmacokinetic Behavior of IB1001, An Investigational Recombinant Factor IX, in Patients with Hemophilia B: Repeat Pharmacokinetic Study and Subgroup Analysis". Blood 118, nr 21 (18.11.2011): 2267. http://dx.doi.org/10.1182/blood.v118.21.2267.2267.
Pełny tekst źródłaKirsch, Ilan, Zijun Yidan Xu-Monette, Thomas Snyder i Ken H. Young. "Defining Immunoglobulin Somatic Hypermutation in De Novo Diffuse Large B-Cell Lymphoma Patients: Potential Application for Prognosis and Risk Stratification". Blood 124, nr 21 (6.12.2014): 1669. http://dx.doi.org/10.1182/blood.v124.21.1669.1669.
Pełny tekst źródłaMinson, Katherine A., Madeline G. Huey, Amanda A. Hill, Irene Perez, Xiaodong Wang, Stephen Frye, H. Shelton Earp, Deborah DeRyckere i Douglas K. Graham. "Bone Marrow Stromal Cell Mediated Resistance to Mertk Inhibition in Acute Leukemia". Blood 128, nr 22 (2.12.2016): 2819. http://dx.doi.org/10.1182/blood.v128.22.2819.2819.
Pełny tekst źródła